Rufinamide

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 374 publications

The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy Participants.

The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy Participants.

Journal: Clinical and translational science

Published: February 24, 2026

Flow Chemistry Meets Green Solvents: Telescoped Synthesis of Triazolyl Phosphoramidates and Phosphinamides in γ-Valerolactone.

Flow Chemistry Meets Green Solvents: Telescoped Synthesis of Triazolyl Phosphoramidates and Phosphinamides in γ-Valerolactone.

Journal: ChemSusChem

Published: January 30, 2026

Current and emerging pharmacotherapies in Lennox-Gastaut syndrome.

Current and emerging pharmacotherapies in Lennox-Gastaut syndrome.

Journal: Expert opinion on pharmacotherapy

Published: June 05, 2025

Development of Triazole based Anticonvulsants through Various Catalytic Approaches.

Development of Triazole based Anticonvulsants through Various Catalytic Approaches.

Journal: Mini reviews in medicinal chemistry

Published: May 18, 2025

In Silico Evaluation of Quinolone-Triazole and Conazole-Triazole Hybrids as Promising Antimicrobial and Anticancer Agents.

In Silico Evaluation of Quinolone-Triazole and Conazole-Triazole Hybrids as Promising Antimicrobial and Anticancer Agents.

Journal: International journal of molecular sciences

Published: May 18, 2025

Rufinamide Mitigates Seizures and Behavioural Deficits via BDNF/TrkB Modulation and Oxidative Stress Reduction in Pentylenetetrazole-Kindled Mice.

Rufinamide Mitigates Seizures and Behavioural Deficits via BDNF/TrkB Modulation and Oxidative Stress Reduction in Pentylenetetrazole-Kindled Mice.

Journal: Clinical and experimental pharmacology & physiology

Published: May 02, 2025

Innovative first-order UV and fluorescence spectroscopic methods for the quantification of rufinamide in the presence of its toxic degradant: Application of AGREE tool.

Innovative first-order UV and fluorescence spectroscopic methods for the quantification of rufinamide in the presence of its toxic degradant: Application of AGREE tool.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: April 24, 2025

Development of isatin-functionalized benzenesulfonamides as novel carbonic anhydrase II and VII inhibitors with antiepileptic potential.

Development of isatin-functionalized benzenesulfonamides as novel carbonic anhydrase II and VII inhibitors with antiepileptic potential.

Journal: European journal of medicinal chemistry

Published: March 15, 2025

Recent Advances in Ionic Mechanisms in Pituitary Cells: Implications for Electrophysiological and Electropharmacological Research.

Recent Advances in Ionic Mechanisms in Pituitary Cells: Implications for Electrophysiological and Electropharmacological Research.

Journal: Journal of clinical medicine

Published: March 10, 2025

Seizure-type-specific treatment responses in Lennox-Gastaut Syndrome: A comprehensive review of pharmacological, neuromodulatory, dietary, and surgical therapies.

Seizure-type-specific treatment responses in Lennox-Gastaut Syndrome: A comprehensive review of pharmacological, neuromodulatory, dietary, and surgical therapies.

Journal: Epilepsy & behavior : E&B

Published: March 10, 2025

Epidemiology and Burden of Illness of Lennox-Gastaut Syndrome in Taiwan: A Retrospective Cohort Study.

Epidemiology and Burden of Illness of Lennox-Gastaut Syndrome in Taiwan: A Retrospective Cohort Study.

Journal: Risk management and healthcare policy

Published: February 14, 2025

Drug-resistant Epilepsy: Which Drugs are Substrates of P-glycoprotein and Which are Not?

Drug-resistant Epilepsy: Which Drugs are Substrates of P-glycoprotein and Which are Not?

Journal: Current neuropharmacology

Published: January 23, 2025

Showing 1-12 of 374

Last Updated: 06/30/2026